title: Antianxiety-like effects of Chimpi (dried citrus peels) in the elevated open-platform test.
abstract: Dried citrus peels (Chimpi) is one of the most common natural medicines with qi (energy flow) rectifying and shi (dampness) drying actions, which originates from Citrus unshiu, and/or C. reticulata according to the definition of the pharmacopoeiae of Japan and China. In this study, the pharmacological effects of their extracts and major chemical constituents hesperidin and its aglycone hesperetin on anxiety were examined with an anxiety model of elevated open-platform test using ICR male mice (6-week-old) and total duration of freezing was decreased in fluoxetine-treated mice, which is a simple and highly sensitive to the effects of serotonergic anxiolytics. Moreover, yokukansankachimpihange (YKH), a combination of yokukansan with Chimpi and Hange (Pinellia) was also examined because Chimpi is considered to play a crucial part in this formula against anxious symptoms in dementia patients. The results showed that Chimpi and YKH possess a significant anxiolytic-like effect similar to that of fluoxetine, suggesting that they might be similar to fluoxetine in their pharmacological actions through the serotonergic neurotransmission pathway. Moreover, it also suggested that the major chemical constituent, hesperidin could be an active principle attributed to the antianxiety-like effects with a direct and indirect role via its aglycone hesperetin.
authors: Kampo Research Laboratories, Kracie Pharma Ltd., Kanebo machi 3-1, Takaoka City, Toyama 933-0856, Japan. ito_aya@phm.kracie.co.jp
authors: Aya
authors: A
authors: Ito
authors: Noriyuki
authors: N
authors: Shin
authors: Takashi
authors: T
authors: Tsuchida
authors: Toshiki
authors: T
authors: Okubo
authors: Hisayoshi
authors: H
authors: Norimoto
mesh_terms: D000818:Animals; D014151:Anti-Anxiety Agents / Q000737:chemistry* / Q000494:pharmacology*; D002851:Chromatography, High Pressure Liquid; D002957:Citrus; D006569:Hesperidin / Q000737:chemistry / Q000494:pharmacology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009043:Motor Activity / Q000187:drug effects
chemical_list: D014151:Anti-Anxiety Agents; D006569:Hesperidin; C013015:hesperetin
references: Brain Res Brain Res Protoc. 1997 Oct;1(4):321-6
references: 9384810
references: Evid Based Complement Alternat Med. 2010 Mar;7(1):69-77
references: 18955273
references: Evid Based Complement Alternat Med. 2011;2011:492691
references: 19965961
references: J Neurochem. 2003 Apr;85(1):180-92
references: 12641740
references: J Agric Food Chem. 2008 Jul 23;56(14):5550-7
references: 18570429
references: Am J Chin Med. 2012;40(3):611-29
references: 22745074
references: Clin Interv Aging. 2012;7:393-6
references: 23055705
references: Psychiatry Clin Neurosci. 2002 Jun;56(3):303-4
references: 12047606
references: Eur J Pharmacol. 2003 Feb 28;463(1-3):55-65
references: 12600702
references: Nihon Yakurigaku Zasshi. 2008 Sep;132(3):155-9
references: 18787297
references: Arch Pharm Res. 2013 May;36(5):641-8
references: 23463336
references: Regul Pept. 2010 Apr 9;161(1-3):97-105
references: 20171995
references: Chem Pharm Bull (Tokyo). 1992 Jul;40(7):1940-2
references: 1394715
references: Pharmacology. 2004 Aug;71(4):174-80
references: 15240993
references: J Ethnopharmacol. 2011 Feb 16;133(3):973-9
references: 20637275
references: J Pharmacol Sci. 2007 Nov;105(3):272-8
references: 17965535
references: J Agric Food Chem. 2012 Feb 1;60(4):877-85
references: 22224368
references: Hum Psychopharmacol. 2013 Jan;28(1):80-6
references: 23359469